Investigation of Genetic Determinants of Capecitabine Toxicity.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Capecitabine (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Pharmacogenomic
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 07 Mar 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
- 02 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.